High serum complement component C4 as a unique predictor of unfavorable outcomes in diabetic stroke
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alawieh A, Elvington A, Tomlinson S (2015a) Complement in the Homeostatic and Ischemic Brain. Front Immunol 6:417. https://doi.org/10.3389/fimmu.2015.00417
Alawieh A, Elvington A, Zhu H, Yu J, Kindy MS, Atkinson C, Tomlinson S (2015b) Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement. J Neuroinflammation 12:247. https://doi.org/10.1186/s12974-015-0464-8
Bao X, Borne Y, Johnson L, Muhammad IF, Persson M, Niu K, Engstrom G (2018) Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the “common soil” hypothesis. Cardiovasc Diabetol 17:87. https://doi.org/10.1186/s12933-018-0733-9
Borne Y et al (2017) Complement C3 associates with incidence of diabetes, but no evidence of a causal relationship. J Clin Endocrinol Metab 102:4477–4485. https://doi.org/10.1210/jc.2017-00948
Carpanini SM, Torvell M, Morgan BP (2019) Therapeutic inhibition of the complement system in diseases of the central nervous system. Front Immunol 10:362. https://doi.org/10.3389/fimmu.2019.00362
Cavusoglu E et al (2007) Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography. Am J Cardiol 100:164–168. https://doi.org/10.1016/j.amjcard.2007.02.075
Cervera A et al (2010) Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS ONE 5:e8433. https://doi.org/10.1371/journal.pone.0008433
Cojocaru IM et al (2008) Changes in plasma levels of complement in patients with acute ischemic stroke. Rom J Intern Med 46:77–80
Copenhaver M, Yu CY, Hoffman RP (2019) Complement components, C3 and C4, and the metabolic syndrome. Curr Diabetes Rev 15:44–48. https://doi.org/10.2174/1573399814666180417122030
Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F (2005) Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 54:570–575. https://doi.org/10.2337/diabetes.54.2.570
Engstrom G, Hedblad B, Janzon L, Lindgarde F (2007) Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil 14:392–397. https://doi.org/10.1097/01.hjr.0000244582.30421.b2
Forti P, Maioli F, Nativio V, Maestri L, Coveri M, Zoli M (2020) Association of prestroke glycemic status with stroke mortality. BMJ Open Diabetes Res Care 8(1):e000957. https://doi.org/10.1136/bmjdrc-2019-000957
Ghebrehiwet B (2016) The complement system: an evolution in progress. F1000Res 5:2840. https://doi.org/10.12688/f1000research.10065.1
Hammad A, Westacott L, Zaben M (2018) The role of the complement system in traumatic brain injury: a review. J Neuroinflammation 15:24. https://doi.org/10.1186/s12974-018-1066-z
Lau LH, Lew J, Borschmann K, Thijs V, Ekinci EI (2019) Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review. J Diabetes Investig 10:780–792. https://doi.org/10.1111/jdi.12932
Li W, Huang E, Gao S (2017) Type 1 diabetes mellitus and cognitive impairments: a systematic review. J Alzheimers Dis 57:29–36. https://doi.org/10.3233/JAD-161250
Lin Z, Lin H, Li W, Huang Y, Dai H (2018) Complement component C3 promotes cerebral ischemia/reperfusion injury mediated by TLR2/NFkappaB activation in diabetic mice. Neurochem Res 43:1599–1607. https://doi.org/10.1007/s11064-018-2574-z
Lubbers R, van Essen MF, van Kooten C, Trouw LA (2017) Production of complement components by cells of the immune system. Clin Exp Immunol 188:183–194. https://doi.org/10.1111/cei.12952
Ma Y, Liu Y, Zhang Z, Yang GY (2019) Significance of complement system in ischemic stroke: a comprehensive review. Aging Dis 10:429–462. https://doi.org/10.14336/AD.2019.0119
Malla G et al (2019) Does the Association of diabetes with stroke risk differ by age, race, and sex? results from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Diabetes Care 42:1966–1972. https://doi.org/10.2337/dc19-0442
Mellbin LG, Bjerre M, Thiel S, Hansen TK (2012) Complement activation and prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care 35:911–917. https://doi.org/10.2337/dc11-1642
Mihindu E, Mohammed A, Smith T, Brinster C, Sternbergh WC 3rd, Bazan HA (2019) Patients with moderate to severe strokes (NIHSS score >10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes. J Vasc Surg 69:1471–1481. https://doi.org/10.1016/j.jvs.2018.07.079
Mocco J et al (2006) Alterations in plasma complement levels after human ischemic stroke. Neurosurgery 59:28–33. https://doi.org/10.1227/01.NEU.0000219221.14280.65 (discussion 28-33)
Nilsson B et al (2014) C3 and C4 are strongly related to adipose tissue variables and cardiovascular risk factors. Eur J Clin Invest 44:587–596. https://doi.org/10.1111/eci.12275
O’Donnell MJ et al (2016) Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet 388:761–775. https://doi.org/10.1016/S0140-6736(16)30506-2
Pedersen ED, Loberg EM, Vege E, Daha MR, Maehlen J, Mollnes TE (2009) situ deposition of complement in human acute brain ischaemia. Scand J Immunol 69:555–562. https://doi.org/10.1111/j.1365-3083.2009.02253.x
Phillips CM et al (2009) Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr 90:1665–1673. https://doi.org/10.3945/ajcn.2009.28101
Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY (2004) Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 18:1–8. https://doi.org/10.1002/jcla.10100
Roth S et al (2018) Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke. Sci Transl Med 10(432):eaao1313. https://doi.org/10.1126/scitranslmed.aao1313
Ruparelia N, Chai JT, Fisher EA, Choudhury RP (2017) Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol 14:314. https://doi.org/10.1038/nrcardio.2017.33
Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127:1–4. https://doi.org/10.1172/JCI92035
Schonenberger S et al (2016) Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 316:1986–1996. https://doi.org/10.1001/jama.2016.16623
Shu L et al (2017) Shared genetic regulatory networks for cardiovascular disease and type 2 diabetes in multiple populations of diverse ethnicities in the United States. PLoS Genet 13:e1007040. https://doi.org/10.1371/journal.pgen.1007040
Stokowska A, Olsson S, Holmegaard L, Jood K, Blomstrand C, Jern C, Pekna M (2011) Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome. Cerebrovasc Dis 32:114–122. https://doi.org/10.1159/000328238
Stokowska A, Olsson S, Holmegaard L, Jood K, Blomstrand C, Jern C, Pekna M (2013) Cardioembolic and small vessel disease stroke show differences in associations between systemic C3 levels and outcome. PLoS One 8:e72133. https://doi.org/10.1371/journal.pone.0072133
Szeplaki G et al (2009) Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis 204:315–320. https://doi.org/10.1016/j.atherosclerosis.2008.07.044